A higher confidence interval for OTC derivatives is typically justified because those products can suffer from less reliable pricing and shorter runs of historical data on which to base exposure estimations. CCPs might clear OTC derivatives that do not suffer from such phenomena and have the same risk characteristics as listed derivatives and they should be able to clear those products consistently irrespective of the execution method.
Recital 27, Commission Delegated Regulation (EU) No 153/2013 of 19 December 2012 supplementing Regul…
In forcesince 19 Dec 2012